NOS2 and neoplasm: Transcriptional upregulation of pro-tumor iNOS/NO in conjunction with PDT and other anti-tumor therapies based on oxidative stress may occur more often than presently realized, thus emphasizing the need for highly effective BET inhibitors like JQ1 as treatment adjuvants.